Vaccine Research Trust
Charity 326276
Overview
Summary
Vaccine Research Trust appears to be a small Birmingham-based research charity whose practical centre of gravity has shifted from funding vaccine research into infectious diseases to preserving, analysing and seeking publication of its founder Dr Gordon Skinner’s clinical thyroid-treatment records. Its role is therefore not primarily public-facing health delivery, but stewardship of a distinctive medical dataset and an associated clinical perspective. The organisation appears financially constrained and strongly shaped by founder legacy and family continuity.
Operational geography
Evidence and reasoning
Supporting evidence
Moseley
Confidence: low
The Trust identifies itself as Birmingham-based and gives a registered address in Moseley. This supports a Moseley administrative base, but the website explicitly describes it as a registered address and does not confirm that research analysis, staff activity or public-facing services are delivered there.
- Vaccine Research Trust website
The Trust describes itself as a Birmingham-based charity and lists its registered address as 22 Alcester Road, Moseley, Birmingham, B13 8BE.
Remaining uncertainties
- The available evidence does not identify the location where the Trust's current thyroid-data analysis is undertaken, or name the researchers or institutions carrying it out.
- There is no current evidence of direct public services, clinics, events or research sites elsewhere in Birmingham.
- The website refers to past support from local businesses and organisations, but does not identify current material delivery partnerships or show that these partnerships extend operations beyond the Trust's Birmingham base.
- Because the only location evidence is a registered address, the Trust's operational footprint may be wider than Moseley or may be administered remotely.
Additional evidence needed
- A current annual report or trustees' report identifying the location of funded research, analysis activity and any grant recipients.
- Confirmation from the Trust of whether 22 Alcester Road is an active working site or correspondence address only.
- Details of any current research, clinical, university, NHS or community partners and the locations at which their work is delivered.
Areas of work
- The Advancement Of Health Or Saving Of Lives
Who they help
- Children/young People
- Elderly/old People
- The General Public/mankind
How they help
- Other Charitable Activities
- Sponsors Or Undertakes Research
Discoveries involving this organisation
The Atlas has not published any Discoveries involving this organisation yet.
Observations
A legacy research charity has narrowed around a distinctive clinical archive
The available evidence suggests that the Trust’s current strategy is centred less on its original vaccine remit and more on analysing and publishing Dr Skinner’s patient data on clinically hypothyroid people whose blood tests were within reference ranges.
Why it matters
This helps explain an apparent mismatch between the charity’s name and its present activity. Its main asset may be a historical dataset and specialised clinical experience, rather than an active vaccine-research programme.
Show evidence
“The Trust says it has traditionally funded research into vaccines against infectious diseases since 1982.”
Source:Organisation“The Trust is supporting analysis of Dr Gordon Skinner’s thyroid work.”
Source:Organisation“The Chairman describes extensive data from Dr Skinner’s practice and a goal to analyse and publish it.”
Source:Organisation
The Trust occupies a contested space between research stewardship and clinical advocacy
Its research purpose appears closely tied to a founder-developed position that some symptomatic patients may need thyroid treatment despite normal laboratory results, including possible use of natural thyroid extract.
Why it matters
This may shape who engages with the Trust, what evidence it prioritises and why publication is framed as both research and a challenge to prevailing clinical practice.
Show evidence
“Dr Skinner treated patients he considered clinically hypothyroid despite normal thyroid chemistry.”
Source:Organisation“The Chairman states that present guidelines consider blood tests the only criteria for diagnosis and treatment.”
Source:Organisation
Continuity depends on a small, founder-connected and financially fragile network
The Trust appears to rely on a compact trustee group, including two of the founder’s children, alongside public fundraising to sustain its work.
Why it matters
This suggests both a strength—long-term commitment to a specialised body of work—and a vulnerability if funding, succession or independent research capacity is limited.
Show evidence
“Two trustees, Fiona Skinner and David Skinner, are Dr Gordon Skinner’s children.”
Source:Organisation“The Trust says it is running low on finance and urgently needs funds.”
Source:Organisation
- Whether the Trust currently funds any vaccine research alongside its thyroid-data work.
- Whether the clinical records have been independently reviewed, analysed or published.
- How much funding, research capacity and external institutional partnership the Trust has.
Remaining uncertainties
- Recent annual reports, accounts and grant records showing expenditure by research area.
- Details of the thyroid dataset, governance approvals, analytic methods and published outputs.
- Evidence of current collaborators, peer review and relationships with research or healthcare institutions.